Hepatitis B virus: advances in prevention, diagnosis, and therapy

MH Nguyen, G Wong, E Gane, JH Kao… - Clinical microbiology …, 2020 - Am Soc Microbiol
Currently, despite the use of a preventive vaccine for several decades as well as the use of
effective and well-tolerated viral suppressive medications since 1998, approximately 250 …

[HTML][HTML] The spectrum of HBV/HCV coinfection: epidemiology, clinical characteristics, viralinteractions and management

D Konstantinou, M Deutsch - … publication of the Hellenic Society of …, 2015 - ncbi.nlm.nih.gov
Monoinfection with either hepatitis B (HBV) or C virus (HCV) represents one of the major
causes of chronic liver disease globally. However, in endemic areas a substantial number of …

[HTML][HTML] Hepatitis B virus and hepatitis C virus dual infection

G Caccamo, F Saffioti, G Raimondo - World journal of …, 2014 - ncbi.nlm.nih.gov
Hepatitis B virus (HBV) and hepatitis C virus (HCV) share common mode of transmission
and both are able to induce a chronic infection. Dual HBV/HCV chronic coinfection is a fairly …

Systematic review: Asian patients with chronic hepatitis C infection

LH Nguyen, MH Nguyen - Alimentary pharmacology & …, 2013 - Wiley Online Library
Summary Background Chronic hepatitis C (CHC) infection is a risk factor for both the
development of end‐stage liver disease and hepatocellular carcinoma (HCC). Globally …

Insights into the coinfections of human immunodeficiency virus-hepatitis B virus, human immunodeficiency virus-hepatitis C virus, and hepatitis B virus-hepatitis C …

S Shahriar, Y Araf, R Ahmad, P Kattel, GS Sah… - Frontiers in …, 2022 - frontiersin.org
Human immunodeficiency virus, hepatitis B virus, and hepatitis C virus are three blood-
borne viruses that can cause major global health issues by increasing severe morbidity …

Circulating programmed death-1 as a marker for sustained high hepatitis B viral load and risk of hepatocellular carcinoma

HY Cheng, PJ Kang, YH Chuang, YH Wang, MC Jan… - PLoS …, 2014 - journals.plos.org
Objective Recent evidence indicates a crucial role of the immunoinhibitory receptor
programmed death-1 (PD-1) in enforcing T-cell dysfunction during chronic viral infection and …

Hepatitis B virus reactivation potentiated by biologics

E Ogawa, MT Wei, MH Nguyen - Infectious Disease Clinics, 2020 - id.theclinics.com
Globally, more than 2 billion people are estimated to have been exposed to the hepatitis B
virus (HBV), 1 and approximately 292 million are chronically infected, 2 making chronic …

An update on the treatment options for HBV/HCV coinfection

E Sagnelli, C Sagnelli, M Macera… - Expert opinion on …, 2017 - Taylor & Francis
Introduction: Despite the reciprocal inhibition exerted by HBV and HCV genomes, dual
HBV/HCV infection is associated with more severe forms of liver disease and warrant …

We are not immune: racial and ethnic disparities in autoimmune liver diseases

BT Lee, MM Tana, JA Kahn, L Dara - Hepatology, 2021 - Wiley Online Library
Autoimmune liver diseases are attributed to a complex interplay of biologic, acquired, and
environmental factors. Increased prevalence, later stage at presentation, worse response to …

Therapeutic Potential of G Protein‐Coupled Receptors Against Nonalcoholic Steatohepatitis

D Sun, X Yang, B Wu, XJ Zhang, H Li, ZG She - Hepatology, 2021 - journals.lww.com
Autoimmune liver diseases are attributed to a complex interplay of biologic, acquired, and
environmental factors. Increased prevalence, later stage at presentation, worse response to …